Wilson Sonsini Goodrich & Rosati advised Ventyx on the deal.Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with…
Ventyx’s $174 Million IPO


Wilson Sonsini Goodrich & Rosati advised Ventyx on the deal.Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with…
…